不明潜质克隆性造血:心肾影响与衰老综述
本文综述不明潜质克隆性造血(CHIP)的病理生理及其对肾脏和心血管系统的影响。CHIP是衰老驱动的造血干细胞克隆性非恶性状态,常见驱动突变为DNMT3A、TET2和ASXL1。CHIP与估算肾小球滤过率下降加快及急性肾损伤风险增加相关,并通过炎症通路增加心血管疾病和动脉粥样硬化风险。
要点
- CHIP患病率随年龄指数增长,常见驱动突变为DNMT3A、TET2和ASXL1。
- CHIP与eGFR下降加快及急性肾损伤风险增加相关。
- CHIP通过炎症通路增加心血管疾病和动脉粥样硬化风险。
核心结论
- CHIP作为一种衰老相关的非恶性克隆性造血状态,与肾脏疾病进展和心血管疾病风险增加相关。
研究设计与样本
- 本文为综述,讨论CHIP通过衰老发生的病理生理、对肾脏疾病的影响及对心血管健康的意义,并将CHIP与意义未明单克隆丙种球蛋白病(MGUS)进行比较。
主要发现
- 采用下一代测序报告CHIP患病率随年龄呈指数增长。
- CHIP与估算肾小球滤过率下降速率更高及急性肾损伤风险增加相关。
- CHIP及其驱动突变通过多种炎症通路增加心血管疾病和动脉粥样硬化风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clonal hematopoiesis of indeterminate potential (CHIP) is a non-malignant state characterized by hematopoietic stem cells exhibiting clonality driven by acquired mutations during aging. Using next-generation sequencing, it has been reported that the prevalence of CHIP increases exponentially with age. Thus far, epigenetic mutations including DNMT3A, TET2 and ASXL1 are the most common mutations identified in driving CHIP. CHIP is considered a pre-malignant state, however with reports of its associations with non-malignant disease states, the clinical impact of CHIP has been of great interest, in particular its effect on the renal and cardiac systems. CHIP has been associated with a higher rate of estimated glomerular filtration rate decline and increased risk of acute kidney injury. CHIP and its driver mutations have also been shown to increase cardiovascular disease and atherosclerosis through various inflammatory pathways. In this review, we discuss the pathophysiology of CHIP through aging, its impact on kidney disease and implications on cardiovascular health. We also compare CHIP to another pre-malignant clonal disorder, monoclonal gammopathy of undetermined significance (MGUS).
引用
- Jalal A, Jhaveri KD, Chowdhury RB, et al. Clonal hematopoiesis of indeterminate potential: a review of its cardiorenal implications and aging. Nephrol Dial Transplant. 2025. PMID: 40107864. doi:10.1093/ndt/gfaf055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。